These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23202454)

  • 1. HIV-1 dynamics: a reappraisal of host and viral factors, as well as methodological issues.
    Prentice HA; Tang J
    Viruses; 2012 Oct; 4(10):2080-96. PubMed ID: 23202454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of viremia in primary HIV-1 infection in Africans: insights from analyses of host and viral correlates.
    Prentice HA; Price MA; Porter TR; Cormier E; Mugavero MJ; Kamali A; Karita E; Lakhi S; Sanders EJ; Anzala O; Amornkul PN; Allen S; Hunter E; Kaslow RA; Gilmour J; Tang J;
    Virology; 2014 Jan; 449():254-62. PubMed ID: 24418560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial.
    Ekenberg C; Tang MH; Zucco AG; Murray DD; MacPherson CR; Hu X; Sherman BT; Losso MH; Wood R; Paredes R; Molina JM; Helleberg M; Jina N; Kityo CM; Florence E; Polizzotto MN; Neaton JD; Lane HC; Lundgren JD
    J Infect Dis; 2019 Sep; 220(8):1325-1334. PubMed ID: 31219150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control.
    Bartha I; Carlson JM; Brumme CJ; McLaren PJ; Brumme ZL; John M; Haas DW; Martinez-Picado J; Dalmau J; López-Galíndez C; Casado C; Rauch A; Günthard HF; Bernasconi E; Vernazza P; Klimkait T; Yerly S; O'Brien SJ; Listgarten J; Pfeifer N; Lippert C; Fusi N; Kutalik Z; Allen TM; Müller V; Harrigan PR; Heckerman D; Telenti A; Fellay J
    Elife; 2013 Oct; 2():e01123. PubMed ID: 24171102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative impact of host and viral factors on HIV-1 viral-load control during early infection.
    Yue L; Prentice HA; Farmer P; Song W; He D; Lakhi S; Goepfert P; Gilmour J; Allen S; Tang J; Kaslow RA; Hunter E
    J Virol; 2013 Jan; 87(2):708-15. PubMed ID: 23115285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-Bw4-B*57 and Cw*18 alleles are associated with plasma viral load modulation in HIV-1 infected individuals in Salvador, Brazil.
    Silva EM; Acosta AX; Santos EJ; Netto EM; Lemaire DC; Oliveira AS; Barbosa CM; Bendicho MT; Galvão-Castro B; Brites C
    Braz J Infect Dis; 2010; 14(5):468-75. PubMed ID: 21221475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of polymorphisms in the HCP5 and HLA-C, and ZNRD1 genes on HIV viral load.
    Thørner LW; Erikstrup C; Harritshøj LH; Larsen MH; Kronborg G; Pedersen C; Larsen CS; Pedersen G; Gerstoft J; Obel N; Ullum H
    Infect Genet Evol; 2016 Jul; 41():185-190. PubMed ID: 27083073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the Impact of Functional Genetic Variation on HIV-1 Control.
    McLaren PJ; Pulit SL; Gurdasani D; Bartha I; Shea PR; Pomilla C; Gupta N; Gkrania-Klotsas E; Young EH; Bannert N; Del Amo J; Gill MJ; Gilmour J; Kellam P; Kelleher AD; Sönnerborg A; Zangerle R; Post FA; Fisher M; Haas DW; Walker BD; Porter K; Goldstein DB; Sandhu MS; de Bakker PIW; Fellay J
    J Infect Dis; 2017 Nov; 216(9):1063-1069. PubMed ID: 28968755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Immunotypes Impose Selection on Viral Genotypes Through Viral Epitope Specificity.
    Gabrielaite M; Bennedbæk M; Zucco AG; Ekenberg C; Murray DD; Kan VL; Touloumi G; Vandekerckhove L; Turner D; Neaton J; Lane HC; Safo S; Arenas-Pinto A; Polizzotto MN; Günthard HF; Lundgren JD; Marvig RL
    J Infect Dis; 2021 Dec; 224(12):2053-2063. PubMed ID: 33974707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa.
    Xie W; Agniel D; Shevchenko A; Malov SV; Svitin A; Cherkasov N; Baum MK; Campa A; Gaseitsiwe S; Bussmann H; Makhema J; Marlink R; Novitsky V; Lee TH; Cai T; O'Brien SJ; Essex M
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):597-609. PubMed ID: 28132517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 continues to replicate and evolve in patients with natural control of HIV infection.
    Mens H; Kearney M; Wiegand A; Shao W; Schønning K; Gerstoft J; Obel N; Maldarelli F; Mellors JW; Benfield T; Coffin JM
    J Virol; 2010 Dec; 84(24):12971-81. PubMed ID: 20926564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host genetics and HIV-1: the final phase?
    Fellay J; Shianna KV; Telenti A; Goldstein DB
    PLoS Pathog; 2010 Oct; 6(10):e1001033. PubMed ID: 20976252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus-induced target cell activation reconciles set-point viral load heritability and within-host evolution.
    Hool A; Leventhal GE; Bonhoeffer S
    Epidemics; 2013 Dec; 5(4):174-80. PubMed ID: 24267873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children.
    Rouet F; Sakarovitch C; Msellati P; Elenga N; Montcho C; Viho I; Blanche S; Rouzioux C; Dabis F; Leroy V;
    Pediatrics; 2003 Oct; 112(4):e289. PubMed ID: 14523214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1.
    Tang J; Tang S; Lobashevsky E; Myracle AD; Fideli U; Aldrovandi G; Allen S; Musonda R; Kaslow RA;
    J Virol; 2002 Aug; 76(16):8276-84. PubMed ID: 12134033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control.
    Caetano DG; Côrtes FH; Bello G; Teixeira SLM; Hoagland B; Grinsztejn B; Veloso VG; Guimarães ML; Morgado MG
    Retrovirology; 2018 Sep; 15(1):62. PubMed ID: 30201008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical comparison of branched DNA and reverse transcriptase-PCR and nucleic acid sequence-based amplification assay for the quantitation of circulating recombinant form_BC HIV-1 RNA in plasma.
    Pan P; Tao X; Zhang Q; Xing W; Sun X; Pei L; Jiang Y
    AIDS; 2007 Dec; 21 Suppl 8():S27-32. PubMed ID: 18172387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class II genotype and the control of viremia in HIV-1-infected individuals on highly active antiretroviral therapy.
    Blankson JN; Siliciano RF
    J Clin Invest; 2001 Mar; 107(5):549-51. PubMed ID: 11238554
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimal timing of viral load monitoring during pregnancy to predict viraemia at delivery in HIV-infected women initiating ART in South Africa: a simulation study.
    Lesosky M; Glass T; Mukonda E; Hsiao NY; Abrams EJ; Myer L
    J Int AIDS Soc; 2017 Nov; 20 Suppl 7(Suppl 7):. PubMed ID: 29171179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.